Examples of 'virologic failure' in a sentence
Meaning of "virologic failure"
Virologic failure is a term commonly used in the field of medicine, specifically related to the treatment of viral infections. It refers to the condition when a prescribed antiviral treatment fails to effectively suppress or control the replication of the virus in the patient's body
How to use "virologic failure" in a sentence
Basic
Advanced
virologic failure
Virologic failure and development of resistance.
Reducing the risk of virologic failure.
Virologic failure all patients.
Absence of prior virologic failure.
Investigators will also evaluate viral resistance in patients experiencing virologic failure.
Facing virologic failure current therapy guidelines recommend switch to an entirely new batch of drugs.
No subject experienced virologic failure.
Of patients with virologic failure in the rilpivirine arm developed concomitant NNRTI and NRTI mutations.
Cross resistance to delavirdine and efavirenz is expected after virologic failure with nevirapine.
Virologic failure relapse and on-treatment failure.
Lack of viral load suppression on ART is termed virologic failure.
On-treatment virologic failure was defined as meeting a virologic stopping rule or having viral breakthrough.
One patient had on-treatment virologic failure.
On-treatment virologic failure was defined as meeting a virologic stopping rule and / or having viral breakthrough.
No subjects experienced on-treatment virologic failure or relapse.
See also
The resulting virologic failure diminishes the potential for long-term clinical success.
No patient experienced on-treatment virologic failure or relapse.
Virologic failure is defined as a confirmed viral load over 200 copies.
No subject experienced on-treatment virologic failure or relapse.
Confirmed virologic failure ( CVF ) was infrequent across both treatment arms.
There was one relapse and no on-treatment virologic failure.
The rate of virologic failure was less than 1 %.
The N88S substitution has been rarely observed in patients with virologic failure on atazanavir treatment.
Three patients had virologic failure at Week 48 ; there was no virologic resistance detected to Genvoya.
Treatment-emergent variants and their prevalence in these virologic failure populations are shown in Table 5.
Number of subjects with virologic failure and paired baseline / endpoint genotypes, developing mutationsb at endpoint, n / N.
Recent data show that minority resistant variants ( MRV ) can be a source of virologic failure.
NOTE, Previous switches for reasons other than virologic failure prior to screening are allowed.
Three GT3b TN subjects experienced relapse and two GT3b TEPRS subjects experienced on-treatment virologic failure.
On-treatment virologic failure.
No patients with genotype 1 HCV had on-treatment virologic failure.
On - treatment virologic failure.
Otherd a No patients with genotype 1 HCV had on-treatment virologic failure.
Number of subjects with virologic failure and paired baseline / endpoint genotypes, developing mutations b at endpoint, n / N.
Other includes patients who did not achieve SVR12 and did not meet virologic failure criteria.
Confirmed virologic failure ( CVF ) was infrequent.
Outcome for patients without SVR On-treatment virologic failure.
On-treatment virologic failure Post-treatment relapse Other.
Outcome for patients without SVR On-treatment virologic failure Relapse b.
No patient experienced virologic failure ( see section 4.2 for information on paediatric use ).
Of the seven patients who did not achieve SVR12, none experienced virologic failure or relapsed.
Non-response Virologic failure ( all patients ).
In the clinical study AGATE-I, one patient with HCV genotype 4a experienced virologic failure on-treatment failure.
Virologic failure ( relapse and on-treatment failure ) Genotype 1a.
Pharmacokinetic data for the 1 patient with on-treatment virologic failure was consistent with non-adherence.
Virologic failure No virologic data at week 48 or week 96 window.
Table 3, Resistance development up to week 96 in protocol defined virologic failure population + early discontinuation population.
Virologic failure - Never suppressed through week 48 - Rebound.
Non-response Virologic failure.
No patients with genotype 2, 4 or 6 HCV infection experienced virologic failure.
You'll also be interested in:
Examples of using Failure
Show more
The failure is stored in the appropriate counters
I will not admit my failure before others
Command failure resulting in loss of control of facility
Examples of using Virologic
Show more
Baseline genotype or phenotype and virologic outcome
There were no virologic failures in the other treatment arms
It is recommended that response to treatment be defined in virologic terms
